Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Rishabh Chalotra has a total of 88 co-authors. Here are the top co-authors by number of shared publications:

  • Randhir Singh

    Laboratory of Neuroendocrinology and Metabolic Disorders, Department of Pharmacology, Central University ofPunjab, Bathinda, India

    9 shared publications
  • Randhir Singh

    Central University of Punjab

    7 shared publications
  • Meenakshi Dhanawat

    Amity Institute of Pharmacy, Amity University Haryana, Amity Education Valley, Panchgaon, Manesar, Gurugram, Haryana 122413, India

    6 shared publications
  • Sumeet Gupta

    Department of Pharmacology, Maharishi Markandeshwar University, Mullana, Ambala, India

    5 shared publications
  • Thakur Gurjeet Singh

    Centre for Research Impact & Outcome, Chitkara College of Pharmacy, Chitkara University, Rajpura, 140401, Punjab, India

    5 shared publications
  • Garima

    4 shared publications

Latest Publications

  • Safety and Efficacy of Curcumin Analogues in Targeting CFA-induced Arthritis

    by Satyavert Loura, Rishabh Chalotra, Inderjeet Verma, Sheenam Sharma, Rishabh Chaudhary, Kirti Goel, Seema Bansal, Swarna Dabral, Sapna Rani, Mohammed Asad, et al.

    Background: Rheumatoid arthritis (RA) is an autoimmune disease characterized by joint inflammation that leads to progressive damage. This condition is marked by immune cell-mediated attacks on the synovial membrane, which leads to the swelling and tenderness of small joints. If unmanaged, these inflammatory processes can lead to cartilage and ligament damage, bone erosion, and a decline in the functionality of affected joints. Objective: The present study aimed to evaluate the acute oral toxicity and anti-rheumatic effects of curcumin analogues in female Wistar rats. Methods: The acute toxicity was assessed using OCED 423 guidelines, and rheumatoid arthritis was induced by injecting 0.1ml of Complete Freund’s Adjuvant (CFA) having 1g/ml Mycobacterium tuberculosis. After confirmation of the disease model, treatment was started and continued for 21 days once daily. The anti-rheumatic activity was assessed by measuring paw volume using a digital plethysmometer. Body weight and haematological parameters, such as haemoglobin levels, erythrocyte sedimentation rate, platelet counts, mean corpuscular haemoglobin, red blood cells count, and Creactive protein, were measured. The interleukin-6 levels were also determined. Histopathological studies were performed to validate the changes in the joint tissue. Results and Discussion: After completion of the study, curcumin analogues did not show any toxic effect after oral administration at a dose of 2000 mg/kg. Treatment with synthesized analogues of curcumin in CFAinduced animals showed a reduction in paw volume. There was a significant improvement in body weight as well as biological markers, such as ESR, CRP, RBC, Hb, MCH, PC, and IL-6. Histopathological observations also supported the macroscopic findings, showing improvements in joint tissues. Conclusion: Hence, it is concluded that curcumin analogues were found to be safe and exhibited anti-rheumatic potential in experimental rats, suggesting their therapeutic role in managing rheumatoid arthritis.

  • Open Access

    Preclinical Evaluation of Fisetin in the Management of Diabetic Foot Ulcer in Wistar Rats

    by Aniket Gupta, Rishabh Chalotra, Randhir Singh

    Aims: Preclinical Evaluation of Fisetin in the Management of Diabetic Foot Ulcer in Wistar Rats. Introduction: Diabetic foot ulcer (DFU) is a complication of diabetes mellitus, often leading to non-traumatic amputations and significantly impacting patient morbidity. Globally, the prevalence of DFU ranges from 9.1 to 26.1 million annually. A 2022 meta-analysis revealed that 6.3% of diabetic adults (33 million) are affected by DFUs. The current treatments primarily focus on topical treatments, neglecting the underlying metabolic conditions. Objective: To investigate the wound healing efficacy of the phytoconstituent fisetin, administered orally, in managing DFU in diabetic neuropathic Wistar rats. Method: This study investigates the therapeutic potential of a phytoconstituent fisetin, in the management of wound healing in STZ-NAD induced diabetic animal model with surgically induced wounds after indication of neuropathy. Fisetin was administered orally at doses of 5, 10, and 15 mg/kg for 30 days following the induction of foot ulcers, Various parameters were measured, including blood glucose levels, HbA1c, lipid profile, pro-inflammatory cytokines, antioxidant activity, MDA, and histopathological analysis of wound healing. Results and Discussion: Fisetin, particularly at 15 mg/kg, significantly modulates blood glucose level, HbA1c, lipid profile, and pro-inflammatory cytokines, further enhancing antioxidant activity, while reducing MDA, indicating a reduction in oxidative stress. Histopathological analysis demonstrated enhanced wound healing by increased fibroblast proliferation and collagen formation, as well as restoration of the epithelial layer. Fisetin also exhibited potential in enhancing re-epithelization, enhancing pro-angiogenic markers, diminishing inflammation, and reducing wound size. Conclusion: Fisetin demonstrates promising potential in managing DFU by modulating metabolic conditions, reducing blood glucose, oxidative stress, and inflammation, and promoting wound healing. Future studies should focus on unraveling the detailed molecular pathways involved in fisetin's action, along with clinical trials to validate its efficacy in DFU patients.


  • Open Access

    Modulation of ion channels as emerging therapeutic targets in the treatment of diabetic neuropathy

    by Tanya Gupta, Alimam Ansari, Rishabh Chalotra, Abhitinder Kumar, Thakur Gurjeet Singh, Randhir Singh

    Diabetic neuropathy (DN) is a prevalent microvascular complication of diabetes mellitus, characterized by hyperalgesia and allodynia that severely impair quality of life. Current treatment approaches do not provide adequate relief, largely due to the multifactorial nature of disease pathogenesis. Growing evidence indicates that dysregulation of multiple ion channel families is a central mechanism underlying sensory neuron hyperexcitability and chronic pain in DN. This review comprehensively discusses the roles of major ion channel families, including voltage-gated sodium (Naᵥ), calcium (Caᵥ), and potassium (Kᵥ) channels, transient receptor potential (TRP) channels, purinergic receptors (P2X/P2Y), and mechanosensitive PIEZO (PIEZO 1 and PIEZO 2) channels, in sensory transmission and pain modulation. Their dysregulation, induced by chronic hyperglycemia and oxidative stress, promotes ectopic firing, altered calcium homeostasis, and glial activation, sustaining nociceptive hypersensitivity. The review further evaluates current and emerging ion channel-targeted therapeutic approaches, highlighting mechanistic insights, translational challenges, and future research directions. Recent research highlights multi-target and combination strategies, such as Naᵥ1.8 inhibition with KCNQ activation or concurrent blockade of TRPV1 and P2X3, as promising avenues offering synergistic analgesic benefits and disease-modifying potential. Advances in nanocarrier-based delivery, gene modulation, and patient-specific electrophysiological profiling further enhance translational prospects. Ultimately, the therapeutic landscape of PDN is shifting from single-channel blockade toward integrated approaches that modulate excitability, inflammation, and metabolic stress concurrently. Ion channels thus represent not only crucial mediators of PDN pathophysiology but also versatile therapeutic targets whose selective and combinatorial modulation may transform the management of diabetic neuropathic pain.

  • Top Cited Papers

    Prebiotics, Probiotics, and Postbiotics in Modulating Gut Microbiota: Emerging Therapeutic Approaches for Metabolic Syndrome

    by Rishabh Chalotra, Tanya Gupta, Abhitinder Kumar, Anjali Gupta, Shivam Kumar, Thakur Gurjeet Singh, Randhir Singh

    This review aims to discuss emerging therapeutic strategies for managing Metabolic Syndrome (MetS) by focusing on modulating the gut microbiota using prebiotics, probiotics, and postbiotics, emphasizing their mechanistic roles in restoring metabolic balance and improving host metabolic health. The biotics exert various pharmacological effects in restoring gut health and managing MetS by modulating multiple gut-system axes, including the gut-brain axis, gut-liver axis, gut-immune axis, and gut-endocrine axis. Through these mechanisms, they influence satiety regulation, insulin sensitivity, bile acid metabolism, systemic inflammation, and overall energy homeostasis, thereby contributing in the management of MetS. This review categorizes therapeutic biotics into three distinct classes: Prebiotics, which serve as substrates to stimulate beneficial bacteria; Probiotics, which supplement the gut with live beneficial microorganisms; and Postbiotics, which are bioactive microbial byproducts that directly modulate host metabolism. Conventional therapies for MetS address individual conditions rather than the syndrome comprehensively, which can promote adverse drug reactions. Whereas, biotic interventions target gut microbiota, a central regulator of energy balance, metabolic signalling and systemic inflammation. By restoring microbial composition and function, these biotics can simultaneously improve insulin sensitivity, reduce inflammation, regulate appetite, and modulate lipid and bile acid metabolism. This multi-dimensional modulation offers biotics as a promising adjunct or complementary strategy, capable of addressing the underlying dysregulation in MetS and offering a more integrative and mechanistic approach to its prevention and management.


  • Top Cited Papers

    Shaping immunotherapy through the tumor microenvironment: Translational perspectives

    by Vansh Vohra, Meenakshi Dhanawat, Rishabh Chalotra, Bharat Bhushan, Garima, Jashan Girdhar, Inamul Hasan Madar, Randhir Singh, Mohammad Fareed


  • Current therapeutic strategies in the management of diabetic foot ulcers

    by Aniket Gupta, Rishabh Chalotra, Kajal Sharma, Anjali Gupta, Shivani Chib, Rohini Agrawal, Thakur Gurjeet Singh, Randhir Singh

    Diabetic foot ulcer (DFU) is a chronic and predominantly microvascular and neuropathic complication in more severe or chronic cases of diabetes mellitus. It is characterized by chronic nonhealing wounds, vascular impairment, and delayed healing process, leading to severe complications, limb amputations, and increased mortality. With an annual incidence rate of approximately 2%, DFU poses a significant global healthcare and economic burden. Despite its prevalence, current treatment options remain limited, necessitating the urgent need for a deeper understanding of the underlying molecular pathways or mechanisms to develop effective therapeutic strategies. Present work is emphasized on molecular mechanisms involved in pathogenesis of DFU and current and emerging therapeutic interventions for the treatment of DFU. Due to its high prevalence, multifaceted pathophysiology, and significant healthcare and economic burden, a thorough understanding of molecular pathways underlying DFU is essential to develop precise therapeutic interventions to improve clinical outcome and reduce the healthcare burden associated with DFU. Several therapeutic interventions have been utilized, like modulators of key signaling pathways (Wnt/β-catenin, PI3K/Akt/mTOR, JAK/STAT, and Notch), repurposed pharmacological agents (e.g. metformin, colchicine, deferoxamine, and lithium carbonate), and advanced local treatments such as bioactive hydrogels and next-generation dressings. Furthermore, regenerative approaches like gene therapy, stem cell transplantation, therapeutic peptides, and 3D-bioprinted adipose tissue constructs provide a promising strategy for restoring tissue integrity and promoting healing.


  • Open Access

    Metabolic syndrome: risk factors and molecular drug targets

    by Rishabh Chalotra, Aniket Gupta, Thakur Gurjeet Singh, Randhir Singh

    Metabolic syndrome (MetS), is a non-communicable disorder caused by impaired management and storage of energy, primarily associated with unhealthy diets, sedentary lifestyles and stress. It is diagnosed when any three of the following conditions are observed, obesity (primary factor), hyperglycemia, low HDL, hypertriglyceridemia, and hypertension (ATP III guidelines). MetS affects approximately 14-34 % of the global population, highlighting significant public health concern. If left untreated, it leads to the development of other serious metabolic diseases like atherosclerosis, diabetes, PCOS, NAFLD, NASH, thyroid, cancer, sleep disturbance, osteoarthritis, anxiety, and depression. Despite ongoing research, no first-line drug currently exists for the comprehensive management of MetS. Its multifactorial nature often requires lifelong polytherapy with lifestyle intervention, raising concern over chronic drug use, drug-drug interactions, increasing morbidity and mortality. Therefore, there is a need highlighting the requirement of a single and targeted pharmacotherapy which offers a safer and more specific therapeutic approach. This review aims to identify and analyse ten key molecular targets in managing the pathogenesis of Metabolic Syndrome (MetS). These targets can further pave the way for a targeted and safer approach in the treatment of MetS.


  • Smart Stimuli-responsive Nanogels: A Potential Tool for Targeted Drug Delivery

    by Meenakshi Dhanawat, Garima, Kashish Wilson, Bharat Bhushan, Rishabh Chalotra, Sumeet Gupta, Pramila Chaubey

    Nanogels (NGs) are presently the focus of extensive research because of their special qualities, including minimal particle size, excellent encapsulating efficacy, and minimizing the breakdown of active compounds. As a result, NGs are great candidates for drug delivery systems. Cross-linked nanoparticles (NPs) called stimulus-responsive NGs are comprised of synthetic, natural, or a combination of natural and synthetic polymers. These NPs can swell in response to large amounts of solvent, but their structural makeup prevents them from dissolving. Furthermore, in response to (i) physical stimuli like temperatures, ion strength, and magnetized or electrical fields; (ii) chemical stimuli like the pH level, molecules, or ions; (iii) biological stimuli like the enzymatic substrate or affinity ligand, they transform into a hard particle (collapsed form) from a polymer solution (swell form). Over the past decade, there has been a major advancement in the creation of “smart” NGs in applications related to therapeutics and diagnosis, involving nucleic acid and intracellular drug delivery, photodynamic/photothermal treatment, biological imaging, and its detection. The nanogels reviewed in this article rely only on temperatures, pH, light, magnetic fields, and combinations of those variables. Developing a targeted delivery vehicle will greatly benefit from the presented information, especially when used for Core-shell multi-sensitive photo-sensitive nanogels.


  • Evaluation of Moringa Oleifera Leaf Extract for its In vitro Antibacterial Properties, Mechanism of Action, and In vivo Corneal Ulcer Healing Effects in Rabbits’ Eyes

    by Ayesha Bibi, Meenakshi Dhanawat, Shahbaz Aman, Samrat Chauhan, Rishabh Chalotra, Somdutt Mujwar, Narinder Kaur, Chamasse Homary Maivagna, Sumeet Gupta

    Background: M. oleifera is the most adapted tree species in different medicinal eco-systems and has resilience against climate changes. This multiple-use tree provides healthy foods, snacks, honey, and fuel. Besides this, it has immense promising applications by offering antimicrobial and antibacterial activities for targeted uses. This validates the court of Hippocrates that let food be the medicine and medicine be the food for which moringa qualifies. Objective: The objective of this study is to assess the antioxidant properties of M. oleifera, in vitro antibacterial activity of hydro-ethanolic extract, and further investigate in vivo healing potential of M. oleifera for corneal ulcers and in silico analysis. Methods: To evaluate the antioxidant and in vitro antibacterial potency of the hydro-ethanolic extract of M. oleifera on clinically isolated multidrug-resistant strains of Staphylococcus aureus using agar well diffusion assay. Furthermore, in vivo, healing response of M. oleifera extract was analysed on corneal ulcers induced in rabbit eyes infected with methicillin-resistant Staphylococcus aureus. Results: The M. oleifera extract exhibited exponential antioxidant activity. In-vitro antibacterial activity was evaluated by agar well diffusion assay showing zone of inhibition ranging from 11.05 ± 0.36 to 20 ± 0.40 mm at concentrations of 20, 40, 80, and 160 mg/ml, whereas, in our finding, no zone of inhibition was observed below 20 mg/ml concentration, which indicated that there is threshold limit below which the antibacterial activity of M. oleifera extract is not observed. Furthermore, continuous application of 3% and 5% M. oleifera extract (eye drop) four times a day for 14 consecutive days showed a significant healing response of the eyes of rabbits with corneal ulcers. Conclusion: These results suggest that M. oleifera extract could be a viable alternative or in combination could be used in existing antibacterial therapies for corneal ulcers. Additionally, there is a possibility of commercial formulation of M. oleifera extract in the form of deliverable pharmaceutical products; therefore, it should be explored further.